-
US appeals court overturns patent case for Jevtana
europeanpharmaceuticalreview
August 20, 2019
Sanofi has won the latest appeal for the patent of its top oncology product, Jevtana (cabazitaxel).
-
Daiichi Sankyo wades deeper into oncology with FDA go-ahead in rare joint cancer
fiercepharma
August 13, 2019
In a win for Daiichi Sankyo’s big pivot to oncology, the Japanese drugmaker has snatched its first U.S. cancer nod since 2011—and it’s also the first FDA-approved drug for a rare joint tumor.
-
Syapse, Pfizer in Oncology Precision Medicine Pact
contractpharma
July 25, 2019
o focus on outcomes research using Real-World Evidence.
-
Ziopharm Oncology Names Chief Financial Officer
drugs
July 25, 2019
Shukla joins the company from Vertex Pharmaceuticals; Served as VP and global Head of Corporate Finance.
-
CytomX Therapeutics Announces Second Target Selection with AbbVie
contractpharma
July 10, 2019
Multi-Program oncology collaboration triggers $10 million milestone payment to CytomX.
-
Ziopharm Oncology Achieves Positive Results for Glioblastoma Treatment
contractpharma
June 19, 2019
Controlled IL-12 platform appears to have activity as a monotherapy and is now being studied in an expanded group of patients.
-
Jeff Settleman, Ph.D., joins Pfizer to lead Oncology Research & Development
worldpharmanews
June 10, 2019
Jeff Settleman, Ph.D., joins Pfizer to lead Oncology Research & Development.
-
Amgen joins with community oncology networks for new research collaboration
worldpharmanews
May 29, 2019
Amgen (NASDAQ: AMGN), along with leading community oncology networks, today announced the launch of Amgen Community Oncology Research Collaborators (ACORC), a new initiative to enhance access by community centers to innovative oncology clinical research.
-
Exclusive: Servier Establishes First U.S. Toehold in Boston with Immediate Focus on Oncology
biospace
May 13, 2019
Less than one year after France-based Servier announced the launch of its U.S. subsidiaryServier Pharmaceuticals, the new company celebrated the grand opening of its 100-employee Boston facility that will initially focus its efforts on developing oncology
-
Verastem Oncology Announces Amendment to Refinance Hercules Loan Facility
firstwordpharma
April 24, 2019
Verastem Oncology Announces Amendment to Refinance Hercules Loan Facility...